Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 147-155

  Legrand, Ollivier ^a   Perrot, Jean Yves ^a   Simonin, Ghislaine ^a   Baudard, Marion ^a   Cadiou, Monique ^a   Blanc, Claude ^a   Ramond, Sylvie ^a   Viguié, Franck ^a   Marie, Jean Pierre ^a   Zittoun, Robert ^a  

^a HÔTEL DIEU   (France)

Author keywords

Biphenotypic acute leukaemia; CD34; Cytogenetics; MDR; Prognostic factors

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CYTOGENETICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 6844259861     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00523.x     Document Type: Article

References (44)

1. Bailly, J.D., Muller, C., Jaffrézou, J.P., Demur, C., Gassar, G., Bordier, C. & Laurent. G. (1995) Lack of correlation between expression and function of Pgp in acute myeloid leukemia cells. Leukemia, 9, 799-807.
2. Ball, E.D., Davis, R.B., Griffin, J.D., Mayer, R.J., Davey, F.R., Arthur, D.C., Wurster-Hill, D., Noll, W., Tarek, M., Allen, S.L., Rai, K., Lee, E.J., Schiffer, C.A. & Bloomfield, C.D. (1991) Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood, 77, 2242-2250.
3. Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Bates, S.E., Berard, C.W., Boycott, J.M., Brophy, N.A., Broxterman, H.J., Chan, H.S.L., Dalton, W.S., Dielt, M., Fojo, A.T., Gascoyne, R.D., Head, D., Houghton, P.J., Kumar Svrivastava, D., Lehnert, M., Leith, C.P., Paietta, E., Pavelic, Z.P., Rimsza, L., Roninson, I.B., Sikic, B.I., Twentyman, P.R., Warnke, R. & Weinstein, R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patient tumors: consensus recommendations. Cancer Research, 56, 3010-3020.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R. & Sultan, C. (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. British Journal of Haematology, 47, 553-561.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 620-625.
6. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R. & Sultan, C. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia. British Journal of Haematology, 78, 325-329.
7. Berger, R., Bernheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Sigaux, F., Flandrin, G. & Boiron, M. (1987) Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Cancer Genetics and Cytogenetics, 28, 293-299.
8. Boldt, D., Kopecky, K.J., Head, D., Gehly, G., Radich, J.P. & Appelbaum, F.R. (1994) Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group Experience. Leukemia, 8, 2118-2126.
9. Buccheri, V., Matutes, E., Dyer, M.J.S. & Catovsky, D. (1995) Lineage commitment in biphenotypic acute leukemia. Leukemia, 7, 919-927.
10. Büchner, T. & Heinecke, A. (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia, 10, (Suppl. 1), S28-S29.
11. Carbonell, F., Swansbury, J., Min, T., Matutes, E., Farahat, N., Buccheri, V., Morilla, R., Secker-Walker, L. & Catovsky, D. (1996) Cytogenetic findings in acute biphenotypic leukemia. Leukemia, 10, 1283-1287.
12. Catovsky, D., Matutes, E., Buccheri, V., Shetty, V., Hanslip, J., Yoshida, N. & Morilla, R. (1991) A classification of acute leukemia for the 1990s. Annals of Hematology, 62, 16-21.
13. Cuneo, A., Michaux, J.L., Ferrant, A., Van Hove, L., Bosly, A., Stul, M., Dal Cin, P., Vandenberghe, E., Cassiman, J.J., Negrini, M., Piva, N., Castoldi, G. & Van Den Berghe, H. (1992) Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood, 79, 720-727.
14. Curtis, A.H., Abaza, M., Sheldon, S., Ross, C.W., Schnitzer, B. & Stoolman, L.M. (1993) Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. British Journal of Haematology, 85, 49-60.
15. Dinndorf, P.A., Andrews, R.G., Benjamin, D., Ridgway, D. & Wolff, L. (1986) Expression of normal myeloid associated antigens by acute leukemia cells. Blood, 67, 1048-1053.
16. Filipits, M., Suchomel, R.W., Zöchbauer S., Brunner, R., Lechner, K. & Pirker, R. (1997) Multidrug resistance-associated protein in acute myeloid leukemia: no impact on treatment outcome. Clinical Cancer Research, 3, 1419-1425.
17. Fourth International Workshop on Chromosomes in Leukemia (1984) Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. Cancer Genetics and Cytogenetics, 11, 332-350.
18. Gale, R.P. & Bassat, I.B. (1987) Hybrid leukaemia. British Journal of Haematology, 65, 261-264.
19. Hanson, C.A., Abaza, M., Sheldon, S., Ross, C.W., Schnitzer, B. & Stoolman, L.M. (1993) Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. British Journal of Haematology, 84, 49-60.
20. Hayashi, Y., Sugita, K., Nakasawa, S., Abe, T., Kojima, S., Inaba, T., Hanada, R. & Yamamoto, K. (1990) Karyotypic patterns in acute mixed lineage leukemia. Leukemia, 4, 121-126.
21. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowroussian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, C., Fulle, H., Ho, A.D., Kuchler, R., Bush, F.W., Schneider, W., Gorg, C., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A. & Messerer, A. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123-133.
22. Hunault, M., Zhou, D.C., Delmer, A., Ramond, S., Viguié, F., Cadiou, M., Perrot, J.Y., Levy, V., Rio, B., Cymbalista, F., Zittoun, R. & Marie, J.-P. (1997) Multidrug resistance (MDR1) gene expression in acute myeloid leukemia: major prognosis significance for the in vivo drug resistance to induction treatment. Annals of Haematology, 74, 65-69.
23. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). Karger, Basel.
24. Kantarjian, H.M., Hirsch-Ginsberg, C., Yee, G., Huh, Y., Freireich, E.J. & Stass, S. (1990) Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxydase-positive blasts by electron microscopy. Blood, 76, 808-813.
25. Kaplan, E.I. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
26. Kita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., Ueda, T., Nasu, K., Kyo, T., Dohy, K. & Kamada, N. (1992) Phenotypical characteristics of acute myelocytic leukemia associated with t(8:21)(q22:q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood, 80, 470-477.
27. Legrand, O., Perrot, J.-Y., Tang, R.P., Simonin, G., Gurbuxani, S., Zittoun, R. & Marie, J.-P. (1996) Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. British Journal of Haematology, 94, 23-33.
28. List, A.F., Spier, C.S., Grogan, T.M., Johson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464-2469.
29. Lo Coco, F., De Rossi, G., Pasqualette, D., Lopez, M., Diverio, D., Latagliata, R., Fenu, S. & Mandelli, F. (1989) CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. British Journal of Haematology, 73, 480-485.
30. Marie, J.-P., Simonin, G., Legrand, O., Delmer, A., Faussat, A.-M., Lewis, A.D., Sikic, B.I. & Zittoun, R. (1995) Glutathione-S-transferases π, μ and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia. Leukemia, 9, 1742-1747.
31. Marie, J.-P., Zhou, D.C., Gurbuxani, S., Legrand, O. & Zittoun, R. (1996) MDR1/P-glycoprotein in haematological neoplasms. European Journal of Cancer, 32A, 1034-1038.
32. Noonan, K.E. & Roninson, I.B. (1991) Quantitative estimation of MDR1 mRNA levels by polymerase chain reaction. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells (ed. by I. B. Robinson), pp. 319-333. Plenum Press, New York.
33. Pui, C.H., Behm, F.G., Singh, B., Rivera, G.K., Schell, M.J., Roberts, W.M., Crist, W.M. & Miro, J., Jr (1989) Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood, 75, 198-202.
34. Reading, C.L., Estey, E.H., Huh, Y.O., Claxton, D.F., Sanchez, G., Terstappen, L.W.M.M., O'Brien, M.C., Baron, S. & Deisseroth, A.B. (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood, 81, 3083-3090.
35. Saikevych, I.A., Kerrigan, D.P., McConnell, T.S., Head, D.R., Appelbaum, F.R. & Willmam, C.L. (1991) Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology. Leukemia, 5. 373-382.
36. Scheffer, G.L., Winjngaard, L.J., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J.L.M., Clevers, H.C. & Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578-582.
37. Seeker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E. & Harrison, G., on behalf of the MRC Adult Leukaemia Working Party (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. British Journal of Haematology, 96, 601-610.
38. Sobol, R.E., Mick, R., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A. & Bloomfield, C.D. (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New England Journal of Medicine, 316, 1111-1117.
39. Stryckmans, P., De Witte, T., Marie, J.-P., Fillet, G., Peeterman, M., Bury, J., Muus, P., Andrien, J.M., Hayat, M., Jaksic, B., Labar, B., Debusscher, L., Solbu, G., Suciu, S. & Zittoun, R., for the EORTC Leukemia Cooperative Study Group (1992) Therapy of adult ALL: overview of two successive EORTC studies (ALL2 and ALL3). Leukemia, 6, (Suppl. 2), 199-203.
40. + acute myeloid leukemia cells. Blood, 82, 3157-3162.
41. Urbano-Ispizua, A., Matutes, E., Villamor, N., Ribera, J.M., Feliu, E., Montserrat, E., Granena, A., Vives-Corrons, J.L. & Rozan. C. (1990) Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. British Journal of Haematology, 75, 202-207.
42. Young, I.T. (1977) Proof without prejudice: use of the Komogorov-Smirnov test for the analysis of histograms from flow systems and other sources. Journal of Histochemistry and Cytochemistry, 25, 935-941.
43. Yunis, J.J., Brunning, R.D., Howe, R.B. & Lobell, M. (1984) High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia. New England Journal of Medicine, 311, 812-818.
44. Zhou, D.C., Zittoun, R. & Marie. J.-P. (1995) Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia, 9, 1661-1666.